2/29/2008

Boston Scientific Corp. announced Thursday that doctors have started to use its implantable Cognis cardiac resynchronization therapy defibrillator and its Teligen implantable cardioverter defibrillator for the treatment of cardiac failure and sudden cardiac arrest in European patients.

Related Summaries